Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.

Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.

UNLABELLED: The Auger electron-emitting radiopharmaceutical 111In-diethylenetriaminepentaacetic acid human epidermal growth factor (111In-DTPA-hEGF) binds the epidermal growth factor receptor (EGFR), is internalized, and translocates to the nucleus. The purpose of this study was to investigate the r...

Full description

Bibliographic Details
Main Authors:	Cai, Z, Chen, Z, Bailey, K, Scollard, D, Reilly, R, Vallis, K
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software.
by: Cai, Z, et al.
Published: (2009)

Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
by: Hu, M, et al.
Published: (2007)

Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
by: Chen, P, et al.
Published: (2002)

ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
by: Cornelissen, B, et al.
Published: (2011)

The anti-tumor effect of the auger electron-emitting radiopharmaceutical, In-111-hEGF against MDA-MB-468 human breast cancer xenografts is tumor-size dependent.
by: Chen, P, et al.
Published: (2001)

Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
by: Bailey, K, et al.
Published: (2007)

Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
by: Reilly, R, et al.
Published: (2006)

A rapid in vivo diagnostical assay to assess the effect of a farnesyl transferase inhibitor on lovo cells using I-123-hEGF
by: Cornelissen, B, et al.
Published: (2003)

Can γH2AX be used to personalise cancer treatment?
by: Shah, K, et al.
Published: (2013)

Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation
by: Owen, J, et al.
Published: (2019)

Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
by: McLarty, K, et al.
Published: (2009)

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
by: McLarty, K, et al.
Published: (2009)

Molecular radiotherapy using cleavable radioimmunoconjugates that target eGFR and γH2AX
by: Cornelissen, B, et al.
Published: (2013)

111In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin.
by: Cornelissen, B, et al.
Published: (2012)

111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin
by: Cornelissen, B, et al.
Published: (2012)

111In-BnDTPA-F3: An Auger electron-emitting radiotherapeutic agent that targets nucleolin
by: Cornelissen, B, et al.
Published: (2012)

Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AX.
by: Cornelissen, B, et al.
Published: (2013)

A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
by: Reilly, R, et al.
Published: (2000)

SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo
by: Song, L, et al.
Published: (2016)

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
by: Cornelissen, B, et al.
Published: (2012)

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
by: Cornelissen, B, et al.
Published: (2012)

111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
by: Reilly, R, et al.
Published: (2000)

In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR
by: Reilly, R, et al.
Published: (2000)

Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.
by: Cornelissen, B, et al.
Published: (2011)

Bringing H2AX into the angiogenesis family.
by: Rankin, E, et al.
Published: (2009)

γH2AX expression in cytological specimens as a biomarker of response to radiotherapy in solid malignancies
by: Shah, K, et al.
Published: (2015)

Induction and quantification of gamma-H2AX foci following low and high LET-irradiation.
by: Leatherbarrow, E, et al.
Published: (2006)

Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.
by: Vallis, K, et al.
Published: (2014)

Histone H2AX phosphorylation in normal human cells irradiated with focused ultrasoft X rays: evidence for chromatin movement during repair.
by: Hamada, N, et al.
Published: (2006)

111In-DTPA-Octreotide SPECT (OctreoScan) uptake in metastatic renal cell carcinoma to the pancreas
by: Chan, K, et al.
Published: (2018)

Biochemical kinetics model of DSB repair and induction of gamma-H2AX foci by non-homologous end joining.
by: Cucinotta, F, et al.
Published: (2008)

Characterising In-111-anti-gamma H2AX-TAT in targeting the DNA damage signal associated with Wnt activated colorectal cancer
by: Konstantinou, M, et al.
Published: (2016)

¹H, ¹³C and ¹⁵N resonance assignments for the fibrillin-1 EGF2-EGF3-hybrid1-cbEGF1 four-domain fragment.
by: Robertson, I, et al.
Published: (2014)

Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Co-administration of Targeting Ligand
by: Song, L, et al.
Published: (2017)

Backbone ¹H, ¹³C and ¹⁵N resonance assignment of the C-terminal EGF-cbEGF pair of LTBP1 and flanking residues.
by: Robertson, I, et al.
Published: (2014)

Effect of pH on phosphorylation of sago starch
by: Muhammad, K., et al.
Published: (2000)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
by: Kaltsas, G, et al.
Published: (1998)

Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide.
by: Isidori, A, et al.
Published: (2002)

Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma
by: Yip , WK
Published: (2008)

Gamma-H2AX foci counting: Image processing and control software for high-content screening
by: Barber, P, et al.
Published: (2007)